World Single-cell Analysis Market Projected to Reach USD 6.56 Billion By 2028, at 14.9% CAGR: Polaris Market Research

According to the research report, the global single-cell analysis market was valued at USD 2.24 billion in 2020 and is expected to reach USD 6.56 Billion By 2028, growing at a CAGR of 14.9% during the forecast period.

Increasing the adoption of the technology in diagnosing and monitoring diseases such as cancer and drug discovery techniques will be the significant factors contributing to global market growth. The increasing approvals for stem cell-based therapies and the emergence of COVID-19 are expected to boost the market's growth further.

Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/single-cell-analysis-market/request-for-sample

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

Top Market Players Are:

Some of the major players operating in the market include Qiagen NV, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Merck Millipore, Illumina Inc., Becton Dickinson & Company, 10x Genomics, Inc., Novogene Corporation, BGI, and Fluidigm Corporation.

The technique is a great tool to detect cancer at an early stage. In the U.S. alone, cancer affected more than 2.2 million people, in 2020, with more than 0.6 million deaths. Treatments fail in cancer as they are diagnosed at an advanced stage. Still, the testing of circulating tumor cells can be detected at an early stage which will significantly help reduce mortality. The testing will also help in developing precision medicine based on the specific biomarker detection in cancer patients.

Single-cell testing is employed in studying the pathogenesis and molecular mechanism of COVID-19. For instance, the technique was used to study the antiviral immunity defects in severely infected COVID-19 patients. The research study found that the patient who is severely affected by the disease have higher expression of apoptotic genes in their dendritic cells along with changes in the expression of primary histocompatibility class II-related genes in a dendritic cell subset known as cDC1c+ DCs that will affect the antigen presentation efficiency of these cells.

Directly Purchase a copy of the report with TOC @ https://www.polarismarketresearch.com/checkouts/9331

The testing has significant applications in the field of oncology, IVF, and Stem Cell technologies. Various technologies such as flow cytometry, polymerase chain reaction (PCR), microscopy, mass spectrometry, next-generation sequencing (NGS) is employed in single-cell testing. Flow cytometry-based testing is more popular than other methods as it can detect both the physical and genetic makeup of the cell.

New developments are taking place in the global market in recent times. For instance, CytoFLEX SRT Benchtop Sorter was launched by Beckman Coulter in March 2021. The expanded color and laser options will increase its use in testing in research laboratories. Similarly, in January 2021, Parse Biosciences received USD 7 million in Series A funding to develop single-cell kits.

Browse detail report with in-depth TOC @ https://www.polarismarketresearch.com/industry-analysis/single-cell-analysis-market

Polaris Market Research has segmented the single-cell analysis market report on the basis of product, application, workflow, end-use, and region:

Single-cell Analysis, Product Outlook (Revenue - USD Million, 2016 - 2028)

Consumables
Reagents
Assay kits
Instruments
Microscopes
Haemocytometers
Flow cytometers
Next-Generation Sequencing (NGS) systems
Polymerase Chain Reaction (PCR) instruments
High content screening systems
Cell microarrays
Automated cell counters
Single live cell imaging

Single-cell Analysis, Application Outlook (Revenue - USD Million, 2016 - 2028)

Cancer
Immunology
Neurology
Stem Cell
Non-invasive Prenatal Diagnosis
In-vitro Fertilization
Others

Single-cell Analysis, Workflow Outlook (Revenue - USD Million, 2016 - 2028)

Single-cell isolation & Library Preparation
Downstream
Data

Single-cell Analysis, End-Use Outlook (Revenue - USD Million, 2016 - 2028)

Academic & Research Laboratories
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Laboratories
Others

Contact Us:
Polaris Market Research
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Ph: +1-929 297-9727

About Us:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

This release was published on openPR.